The infusion services sector has drawn steady private equity investment in recent years, driven by its promising growth potential and critical role in patient care. However, in passing the “gold rush” era, there is still great revenue opportunity for consolidation with strategic optimization. This is a pivotal moment in infusion services for providers and investors […]
Four Critical Value Levers for Infusion Services Read More »
You are unauthorized to view this page. Username Password Remember Me Forgot Password
Four Critical Value Levers for Infusion Services Read More »
Revelstoke Capital Partners (“Revelstoke”), a growth-oriented healthcare-focused private equity firm, announces it has completed a recapitalization of AOM Infusion (“AOM” or the “Company”). AOM, a specialty infusion provider focused on chronic therapy management, is the ninth investment from Revelstoke Capital Partners Fund III. AOM Infusion provides patients with Intravenous Immunoglobulin (“IVIG”), biologics and other therapies,
Revelstoke Capital Partners Makes Significant Investment in AOM Infusion Read More »
You are unauthorized to view this page.
Revelstoke Capital Partners Makes Significant Investment in AOM Infusion Read More »
Peak Mobile Holdings, a national leader in mobile healthcare services focused on preventing hospital admissions and readmissions, proudly announces the acquisition of New England Vascular Access, a premier provider of mobile vascular access services across New Hampshire, Vermont, and Maine. New England Vascular Access brings a team of highly trained vascular access professionals who specialize
You are unauthorized to view this page.
You are unauthorized to view this page.
BioMatrix Infusion Pharmacy Acquires MyLyfe Health Read More »
BioMatrix Infusion Pharmacy, a leading provider in ambulatory and home infusion services, has announced the acquisition of MyLyfe Health. MyLyfe Health specializes in specialty pharmacy, home infusion, and infusion suite services for patients with chronic, lifelong medical conditions. This strategic acquisition strengthens BioMatrix’s position in the infusion pharmacy market, expanding its capabilities to better serve
BioMatrix Infusion Pharmacy Acquires MyLyfe Health Read More »
Rubicon Founders, a healthcare investment firm focused on building and growing transformational companies, announces that it has made a majority investment in Horizon Infusions, Ohio’s largest network of ambulatory infusion centers. BroadOak Capital will continue as a minority investor in Horizon Infusions. Horizon Infusions operates 21 centers statewide, providing critical infusion therapies to patients with
Rubicon Founders Announces Investment in Horizon Infusions to Support Expansion Read More »
